Status:
COMPLETED
Brief Introductory Therapy for Opioid Dependence
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opiate Dependence
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
A randomized clinical trial to compare the efficacy of Behavioral Drug and HIV Risk Reduction Counseling (BDRC) and standard methadone drug counseling.
Detailed Description
The proposed study plans to compare the efficacy of behavioral drug and HIV risk reduction counseling (BDRC) to low intensity methadone counseling during methadone maintenance treatment. In selecting ...
Eligibility Criteria
Inclusion
- opioid dependence
Exclusion
- suicide or homicide risk
- psychiatric disorder requiring medication treatment
- life threatening or unstable medical problems
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT00406484
Start Date
September 1 2004
End Date
September 1 2010
Last Update
April 2 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Methadone Research Unit, The APT Foundation, Inc.
New Haven, Connecticut, United States, 06519
2
Yale University School of Medicine
New Haven, Connecticut, United States, 06519